Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France

BACKGROUND AND AIMS: The heterogeneous nature of breast cancer can make decisions on adjuvant chemotherapy following surgical resection challenging. Oncotype DX is a validated gene expression profiling test that predicts the likelihood of adjuvant chemotherapy benefit in early-stage breast cancer. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Katz, Gregory, Romano, Olivier, Foa, Cyril, Vataire, Anne-Lise, Chantelard, Jean-Victor, Hervé, Robert, Barletta, Hugues, Durieux, Axel, Martin, Jean-Pierre, Salmon, Rémy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472722/
https://www.ncbi.nlm.nih.gov/pubmed/26086912
http://dx.doi.org/10.1371/journal.pone.0128880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472722/
https://www.ncbi.nlm.nih.gov/pubmed/26086912
http://dx.doi.org/10.1371/journal.pone.0128880

Ejemplares similares